Literature DB >> 7635629

Increased antimalarial activity of azithromycin during prolonged exposure of Plasmodium falciparum in vitro.

A E Yeo1, K H Rieckmann.   

Abstract

The minimum inhibitory concentration, MIC, of azithromycin was determined for 2 isolates of Plasmodium falciparum at 48 and 96 h. The MIC at 48 h for the K1 and FC isolates were 6.2 and 8.7 micrograms/ml, respectively. At 96 h, the MIC decreased to 0.08 microgram/ml for the K1 isolate and 0.04 microgram/ml for the FC isolate. The marked reduction in the MIC values between the first and second asexual erythrocytic cycles suggests that the drug acts slowly and that it may have to be used in combination with a faster acting drug.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7635629     DOI: 10.1016/0020-7519(94)00119-9

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  16 in total

1.  In vitro activities of antibiotics against Plasmodium falciparum are inhibited by iron.

Authors:  B Pradines; C Rogier; T Fusai; J Mosnier; W Daries; E Barret; D Parzy
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

2.  Pharmacokinetics of oral doxycycline during combination treatment of severe falciparum malaria.

Authors:  Paul N Newton; Jean-François Chaulet; Alan Brockman; Wirongrong Chierakul; Arjen Dondorp; Ronatrai Ruangveerayuth; Sornchai Looareesuwan; Cyril Mounier; Nicholas J White
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

3.  Multiple antibiotics exert delayed effects against the Plasmodium falciparum apicoplast.

Authors:  Erica L Dahl; Philip J Rosenthal
Journal:  Antimicrob Agents Chemother       Date:  2007-08-13       Impact factor: 5.191

4.  Pharmacokinetics and ex vivo antimalarial activity of artesunate-azithromycin in healthy volunteers.

Authors:  Nguyen Trong Chinh; Nguyen Ngoc Quang; Chu Xuan Anh; Nguyen Xuan Thanh; Bui Dai; Geoffrey W Birrell; Marina Chavchich; Michael D Edstein
Journal:  Antimicrob Agents Chemother       Date:  2011-07-05       Impact factor: 5.191

5.  In vitro and in vivo activity of solithromycin (CEM-101) against Plasmodium species.

Authors:  Sergio Wittlin; Eric Ekland; J Carl Craft; Julie Lotharius; Ian Bathurst; David A Fidock; Prabhavathi Fernandes
Journal:  Antimicrob Agents Chemother       Date:  2011-11-14       Impact factor: 5.191

6.  In vivo and in vitro antimalarial properties of azithromycin-chloroquine combinations that include the resistance reversal agent amlodipine.

Authors:  Marcus R Pereira; Philipp P Henrich; Amar Bir Singh Sidhu; David Johnson; Joel Hardink; Jeffrey Van Deusen; Jian Lin; Katrina Gore; Connor O'Brien; Mamadou Wele; Abdoulaye Djimde; Richa Chandra; David A Fidock
Journal:  Antimicrob Agents Chemother       Date:  2011-04-04       Impact factor: 5.191

7.  Development of a novel human CD147 knock-in NSG mouse model to test SARS-CoV-2 viral infection.

Authors:  Saiaditya Badeti; Qingkui Jiang; Alireza Naghizadeh; Hsiang-Chi Tseng; Yuri Bushkin; Salvatore A E Marras; Annuurun Nisa; Sanjay Tyagi; Fei Chen; Peter Romanienko; Ghassan Yehia; Deborah Evans; Moises Lopez-Gonzalez; David Alland; Riccardo Russo; William Gause; Lanbo Shi; Dongfang Liu
Journal:  Cell Biosci       Date:  2022-06-11       Impact factor: 9.584

8.  Assessment of azithromycin in combination with other antimalarial drugs against Plasmodium falciparum in vitro.

Authors:  Colin Ohrt; George D Willingmyre; Patricia Lee; Charles Knirsch; Wilbur Milhous
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

9.  Telithromycin and quinupristin-dalfopristin induce delayed death in Plasmodium falciparum.

Authors:  Diana Barthel; Martin Schlitzer; Gabriele Pradel
Journal:  Antimicrob Agents Chemother       Date:  2007-12-03       Impact factor: 5.191

10.  Pharmaceutical development and optimization of azithromycin suppository for paediatric use.

Authors:  Tina Kauss; Alexandra Gaubert; Chantal Boyer; Boubakar B Ba; Muriel Manse; Stephane Massip; Jean-Michel Léger; Fawaz Fawaz; Martine Lembege; Jean-Michel Boiron; Xavier Lafarge; Niklas Lindegardh; Nicholas J White; Piero Olliaro; Pascal Millet; Karen Gaudin
Journal:  Int J Pharm       Date:  2012-12-03       Impact factor: 5.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.